[1]
“Observational analysis of 12 years-experience with OnabotulinumtoxinA in the treatment of chronic migraine treated in a tertiary headache center”, Headache Med, vol. 14, no. Supplement, p. 131, Dec. 2023, Accessed: Jan. 22, 2026. [Online]. Available: https://headachemedicine.com.br/hm/article/view/992